Showing results (81-90 of 268) with videos related to

Sort By:
Pageof 27
Cancer Research|July 10, 2007
Requirement for IFN-gamma, CD8+ T lymphocytes, and NKT cells in talactoferrin-induced inhibition of neu+ tumorsMichela Spadaro, Claudia Curcio, Atul Varadhachary, et al.
Plos One|September 4, 2014
A mathematical-biological joint effort to investigate the tumor-initiating ability of Cancer Stem CellsChiara Fornari, Marco Beccuti, Stefania Lanzardo, et al.
Cancers|December 11, 2025
Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of CancerLidia Tarone, Antonella Iacoviello, Antonino Di Lorenzo, et al.
Children (Basel, Switzerland)|November 25, 2023
A High Copy Number from a Pharyngeal Swab Is Not Associated with Different Presenting Features in 100 Children with Acute Adenovirus Infection from a Cluster in ItalyAnthea Mariani, Federica Cavallo, Saverio La Bella, et al.
Vaccine|April 20, 2005
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c miceElena Quaglino, Cristina Mastini, Manuela Iezzi, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 1, 2020
Role of Radiotherapy in Post-transplant Lymphoproliferative Disorders: Three Case Reports and Review of the LiteratureErika Orlandi, Giuseppe Carlo Iorio, Sara Bartoncini, et al.
Cancer Research|August 4, 2006
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-toleranceElena Ambrosino, Michela Spadaro, Manuela Iezzi, et al.
Journal of Translational Medicine|July 3, 2017
CSPG4: a prototype oncoantigen for translational immunotherapy studiesValeria Rolih, Giuseppina Barutello, Selina Iussich, et al.
European Journal of Haematology|March 8, 2006
Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myelomaAntonio Palumbo, Ilaria Avonto, Benedetto Bruno, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 24, 2013
The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cellsLaura Conti, Stefania Lanzardo, Maddalena Arigoni, et al.
Pageof 27